Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2020-11-12 Capital/Financing Update
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Underwriting or agency agreements (or amendment thereto).pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'UNDERWRITING AGREEMENT' and details the sale of units consisting of common shares and warrants by Aurora Cannabis Inc. It includes detailed terms of the offering, references to Canadian and U.S. securities regulatory filings, prospectuses, registration statements (Form F-10), and the involvement of underwriters. The content is focused on the terms and conditions of a capital raising transaction, including the number of units, pricing, regulatory approvals, and representations and warranties by the corporation. This is clearly a document related to a financing transaction rather than a financial report, management discussion, or regulatory filing unrelated to capital raising. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the agreement itself, not a brief announcement or certification, supporting a high confidence classification.
2020-11-12 English
Consent letter of issuer's legal counsel.pdf
Capital/Financing Update Classification · 95% confidence The document is a letter from McMillan LLP providing consent related to a Prospectus Supplement dated November 11, 2020, for Aurora Cannabis Inc. It references legal opinions and confirms no misrepresentations in the Prospectus Supplement. The document is short (1674 characters) and is clearly a legal consent letter related to a financing prospectus, not a full report or financial statement. It does not contain financial data or detailed report content but is related to a capital raising document. Therefore, it fits best under Capital/Financing Update (CAP) as it pertains to a financing prospectus supplement and legal consent thereto.
2020-11-12 English
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter of consent from a law firm regarding references to their name and opinion in a prospectus supplement related to an offering of units by Aurora Cannabis Inc. It is addressed to multiple securities commissions and confirms no misrepresentations in the prospectus supplement. The document is short (1864 characters) and does not contain financial statements or detailed financial data. It is not the prospectus supplement itself but a legal consent related to it. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2020-11-12 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release dated November 11, 2020, announcing the pricing of a US$150 million underwritten public offering by Aurora Cannabis Inc. It details the offering structure, underwriters, use of proceeds, and regulatory filing plans including a prospectus supplement and registration statement filings with Canadian and U.S. securities regulators. The content focuses on capital raising activities and financing details rather than financial results, management changes, or regulatory certifications. The document length is 8725 characters, which is substantive and contains detailed information about the financing event. Therefore, this document fits the category of a Capital/Financing Update (CAP).
2020-11-11 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release dated November 10, 2020, announcing a proposed public offering by Aurora Cannabis Inc. It details the terms of the offering, including the number of units, pricing, and use of proceeds. It references the filing of a preliminary prospectus supplement and a base shelf prospectus, as well as registration statements with securities commissions and the SEC. The document is an announcement of a financing activity, specifically a public offering of securities, and does not contain financial statements or detailed financial analysis. It is not a full report but an update on capital raising plans. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (8834 characters) supports that it is a detailed announcement rather than a brief notice or a full report.
2020-11-11 English
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Regulatory Filings
2020-11-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.